Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CATEQUENTINIB vs CEFEPIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CATEQUENTINIB vs CEFEPIME: Safety Overview

Metric CATEQUENTINIB CEFEPIME
Total FAERS Reports 324 5,540
Deaths Reported 44 997
Death Rate 13.6% 18.0%
Hospitalizations 115 3,055
Average Patient Age 57.2 yrs 56.5 yrs
% Female Patients 38.7% 47.6%
FDA Approval Date N/A Aug 21, 2018
Manufacturer N/A Apotex Corp.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued